Searched for
ZETIA SUN PHARMA
Glenmark readies specialty, innovative pipeline as pricing challenges loom in the USGlenmark’s consolidated net profit saw a deep cut, dropping 78 per cent to Rs. 104.7 crore.- Sun Pharma receives USFDA nod for anti-cholesterol drug"As per IMS, ezetimibe tablets had annual sales of approximately USD 2.7 billion in the US for the 12 months ended April 2017," it added.
- Techno funda: 100 stocks are readying for a rally, suggests MACDSome counters have been witnessing strong trading volumes, supporting the emerging trend.
- Nifty Pharma trading up, Sun Pharma top gainerAmong the 51 stocks in Nifty index, 37 were trading in green, while 14 were in red.
- Sensex rises over 100 points; Nifty above 9,600; Sun Pharma, UltraTech top gainersAfter opening on a flat note, the BSE Sensex was trading 100 points up at 31,195.
- Top stocks in focus on Tuesday, 13 June 2017US Fed’s meet will loom over the market while poor IIP numbers may kill feel-good factor.
- Pricing pressure in US to keep pharma companies' growth under checkDr Reddy's Lab is expected to report subdued numbers in 3QFY17, with revenue declining 6.1 per cent Y-o-Y to Rs 37.2 billion and PAT down 2...
- Fifteen stocks in focus on Tuesday, 13 December 2016Dairy firm Kwality on Monday reported a 12 per cent increase in its net profit at Rs 42.07 crore for the second quarter of this fiscal. The...
- After Trump win, pharma is best sector to stick with: Hemang Jani, Sharekhan“We like Glenmark Pharma and Aurobindo because these two companies have extremely high approval rates”
- USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
- Indian companies get USFDA nod for 14 1st-time generic drugs in 2015Indian pharma firms accounted for 14 of total 90 first-time generic drug approvals granted by the United States Food and Drug Administratio...
- Despite being on rough end, annual report from US FDA’s OGD shows Indian firms won key approvals in 2015The annual report released by the FDA’s OGD shows Indian companies have won some key approvals in the world’s biggest pharmaceuticals marke...
- Trileptal copy seen boosting Glenmark's US sales by $20 mnIndia’s Glenmark Pharmaceuticals is likely to record sales of about $20 million in the United States for its generic version of Novartis’ e...
Load More
